| 17beta-estradiol | increases expression | ISO | RGD:1319734 | 6480464 | Estradiol results in increased expression of FBXO5 mRNA | CTD | PMID:16474171 |
| 17beta-estradiol | increases expression | ISO | RGD:1319734 | 6480464 | Estradiol results in increased expression of FBXO5 mRNA | CTD | PMID:16474171 PMID:19167446 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1319734 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of FBXO5 mRNA | CTD | PMID:21802500 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1319734 | 6480464 | Tetrachlorodibenzodioxin affects the expression of FBXO5 mRNA | CTD | PMID:22574217 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of FBXO5 mRNA | CTD | PMID:21570461 |
| 2-methylcholine | affects expression | ISO | RGD:1319734 | 6480464 | beta-methylcholine affects the expression of FBXO5 mRNA | CTD | PMID:21179406 |
| 3,4-methylenedioxymethamphetamine | increases expression | EXP | | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of FBXO5 mRNA | CTD | PMID:20188158 |
| 4-hydroxynon-2-enal | decreases expression | EXP | | 6480464 | 4-hydroxy-2-nonenal results in decreased expression of FBXO5 mRNA | CTD | PMID:19191707 |
| 4-hydroxynon-2-enal | increases expression | EXP | | 6480464 | 4-hydroxy-2-nonenal results in increased expression of FBXO5 mRNA | CTD | PMID:19191707 |
| 5-fluorouracil | decreases expression | ISO | RGD:1319734 | 6480464 | Fluorouracil results in decreased expression of FBXO5 mRNA | CTD | PMID:16557594 |
| 5-fluorouracil | decreases expression | EXP | | 6480464 | Fluorouracil results in decreased expression of FBXO5 mRNA | CTD | PMID:19272435 |
| aflatoxin B1 | affects expression | ISO | RGD:1319734 | 6480464 | Aflatoxin B1 affects the expression of FBXO5 protein | CTD | PMID:20106945 |
| aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of FBXO5 mRNA | CTD | PMID:19770486 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in increased expression of FBXO5 mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1319734 | 6480464 | Benzo(a)pyrene results in decreased expression of FBXO5 mRNA | CTD | PMID:21632981 more ... |
| benzo[a]pyrene | decreases expression | ISO | RGD:1319734 | 6480464 | Benzo(a)pyrene results in decreased expression of FBXO5 mRNA | CTD | PMID:21802500 PMID:22316170 |
| bisphenol A | increases expression | ISO | RGD:1319734 | 6480464 | bisphenol A results in increased expression of FBXO5 mRNA | CTD | PMID:16474171 |
| calcitriol | decreases expression | ISO | RGD:1319734 | 6480464 | Calcitriol results in decreased expression of FBXO5 mRNA | CTD | PMID:21592394 |
| calcitriol | multiple interactions | ISO | RGD:1319734 | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of FBXO5 mRNA | CTD | PMID:21592394 |
| cefaloridine | increases expression | ISO | RGD:1309405 | 6480464 | Cephaloridine results in increased expression of FBXO5 mRNA | CTD | PMID:18500788 |
| cobalt dichloride | decreases expression | ISO | RGD:1319734 | 6480464 | cobaltous chloride results in decreased expression of FBXO5 mRNA | CTD | PMID:19320972 |
| copper atom | multiple interactions | ISO | RGD:1319734 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of FBXO5 mRNA | CTD | PMID:20971185 |
| copper(0) | multiple interactions | ISO | RGD:1319734 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of FBXO5 mRNA | CTD | PMID:20971185 |
| copper(2+) sulfate | decreases expression | ISO | RGD:1319734 | 6480464 | Copper Sulfate results in decreased expression of FBXO5 mRNA | CTD | PMID:19549813 |
| coumestrol | multiple interactions | ISO | RGD:1319734 | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of FBXO5 mRNA; more ... | CTD | PMID:19167446 |
| coumestrol | increases expression | ISO | RGD:1319734 | 6480464 | Coumestrol results in increased expression of FBXO5 mRNA | CTD | PMID:19167446 |
| cyclosporin A | affects expression | ISO | RGD:1319734 | 6480464 | Cyclosporine affects the expression of FBXO5 mRNA | CTD | PMID:20106945 |
| cyclosporin A | decreases expression | ISO | RGD:1319734 | 6480464 | Cyclosporine results in decreased expression of FBXO5 mRNA | CTD | PMID:21632981 |
| dasatinib (anhydrous) | decreases expression | ISO | RGD:1319734 | 6480464 | dasatinib results in decreased expression of FBXO5 mRNA | CTD | PMID:20579391 |
| dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of FBXO5 mRNA | CTD | PMID:21266533 |
| dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of FBXO5 mRNA | CTD | PMID:17361019 PMID:21266533 |
| fulvestrant | multiple interactions | ISO | RGD:1319734 | 6480464 | [fulvestrant co-treated with Sirolimus] results in decreased expression of FBXO5 mRNA | CTD | PMID:19016759 |
| fulvestrant | decreases expression | ISO | RGD:1319734 | 6480464 | fulvestrant results in decreased expression of FBXO5 mRNA | CTD | PMID:19016759 |
| furan | increases methylation | ISO | RGD:1309405 | 6480464 | furan results in increased methylation of FBXO5 gene | CTD | PMID:22079235 |
| genistein | increases expression | ISO | RGD:1319734 | 6480464 | Genistein results in increased expression of FBXO5 mRNA | CTD | PMID:16474171 |
| hydroquinone | decreases expression | ISO | RGD:1319734 | 6480464 | hydroquinone results in decreased expression of FBXO5 mRNA | CTD | PMID:23416264 |
| lucanthone | decreases expression | ISO | RGD:1319734 | 6480464 | Lucanthone results in decreased expression of FBXO5 mRNA | CTD | PMID:21148553 |
| paracetamol | increases expression | ISO | RGD:1319734 | 6480464 | Acetaminophen results in increased expression of FBXO5 mRNA | CTD | PMID:22230336 |
| phenobarbital | affects expression | EXP | | 6480464 | Phenobarbital affects the expression of FBXO5 mRNA | CTD | PMID:23091169 |
| pirinixic acid | multiple interactions | EXP | | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of FBXO5 mRNA | CTD | PMID:19710929 |
| quercetin | decreases expression | ISO | RGD:1319734 | 6480464 | Quercetin results in decreased expression of FBXO5 mRNA | CTD | PMID:21632981 |
| resveratrol | multiple interactions | ISO | RGD:1319734 | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of FBXO5 mRNA | CTD | PMID:19167446 |
| sirolimus | multiple interactions | ISO | RGD:1319734 | 6480464 | [fulvestrant co-treated with Sirolimus] results in decreased expression of FBXO5 mRNA | CTD | PMID:19016759 |
| sodium dichromate | affects expression | ISO | RGD:1309405 | 6480464 | sodium bichromate affects the expression of FBXO5 mRNA | CTD | PMID:22110744 |
| testosterone | multiple interactions | ISO | RGD:1319734 | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of FBXO5 mRNA | CTD | PMID:21592394 |
| testosterone | decreases expression | ISO | RGD:1319734 | 6480464 | Testosterone results in decreased expression of FBXO5 mRNA | CTD | PMID:21592394 |
| tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of FBXO5 mRNA | CTD | PMID:17484886 |
| trans-resveratrol | multiple interactions | ISO | RGD:1319734 | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of FBXO5 mRNA | CTD | PMID:19167446 |
| trimellitic anhydride | increases expression | EXP | | 6480464 | trimellitic anhydride results in increased expression of FBXO5 mRNA | CTD | PMID:19042947 |
| valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of FBXO5 mRNA | CTD | PMID:15799026 |
| vanadyl sulfate | decreases expression | ISO | RGD:1319734 | 6480464 | vanadyl sulfate results in decreased expression of FBXO5 mRNA | CTD | PMID:16330358 |